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Abstract
Background: Mass spectrometry based screening methods have been
recently introduced into clinical proteomics. This boosts the development
of a new approach for early disease detection: proteomic pattern analysis.
Aim: Find, analyze and compare proteomic patterns in groups of patients
having different properties such as disease status or epidemio-logical pa-
rameters (e.g. sex, age) with a new pipeline to enhance sensitivity and
specificity.
Problems: Mass data acquired from high-throughput platforms frequently
are blurred and noisy. This extremely complicates the reliable identifica-
tion of peaks in general and very small peaks below noise-level in partic-
ular.
Approach: Apply sophisticated signal preprocessing steps followed by
statistical analyzes to purge the raw data and enable the detection of real
signals while maintaining information for tracebacks.
Results: A new analysis pipeline has been developed capable of finding
and analyzing peak patterns discriminating different groups of patients
(e.g. male/female, cancer/healthy). First steps towards distributed com-
puting approaches have been incorporated in the design.
Introduction
Todays mass spectrometry protein fingerprinting techniques rely on the analy-
sis of highly complex spectra obtained by high-troughput platforms in clinical
settings. Algorithms have to deal with a substantial amount of noise, system-
atic errors introduced by the machines, biochemical degradation processes in the
samples, and difficult and error-prone ionization techniques. Within this “cross-
fire of influences” they seek to isolate and analyze signals leading to biomarkers
possibly being useful for further clinical studies.
Preliminary Achievements
In the first 8 (of 12 estimated) months of this project a pipeline has been de-
signed and implemented that preprocesses the raw data, provided by the group
of Prof. Thiery1, distills relevant signals and analyzes these features for several
tasks.
1More than 10.000 spectra from about 750 apparently healthy individuals, taken and eval-
uated at the University Hospital Leipzig.
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First stage low-level preprocessing techniques such as smoothing and reduc-
tion of the baseline applied to the raw data prepare the signal. During the
second stage peaks in the adjusted signal are sought for and properties, such as
width, height, or shape of these peaks are stored in a database. Unlike other
methods we do not apply noise-filtering because our studies have shown this to
result in loss of many pivotal marker. These sets of peaks for each spectrum
will be used as the basis for detection of markers for discrimination of patient
groups and further analyzes, such as correlation detection between peaks and
particular blood-parameters.
Each of these individual steps has a sanity check and every intermediate
result is assigned a quality value together with a link to the preceding result to
provide reliable, verifiable results.
The third level of algorithms are the actual analyzes working on the reliable
distilled features from the preceding steps. These analyzes cover two main
directions at the moment:
• Finding Differential Peak Patterns between groups of patients
(e.g. male/female, cancer/healthy)
• Analyzing correlations of peaks to blood parameters or patient meta-data
For the automated, quick and easy usage of the pipeline and to hide the
wiring of the algorithms from the user a .NET 2.0 web front-end has been
designed that directly interacts with the MS-SQL 2005 database. This front-
end executes and controls the algorithms, manages the data and visualizes the
results.
With this suite of algorithms and the vast amount of clinical data from
our project partners2 we were able to outperform state-of-the-art commercial
software products such as ClinProtTools3 by more than 10% in specificity
and sensitivity. These results will be submitted for publication until
the end of Februray 2006.
Future Goals
Up until now the project has generated very important experience for handling
mass spectrometry data and crucial algorithms for preprocessing and analysis
of them. This toolbox has been tied together in an execution pipeline with
defined input and output interfaces, wrapped up by a web front-end and pro-
vides its data to other services in a defined and documented high-performance
database environment. Thanks to its modular implementation, parts are easily
exchangeable and new algorithms can be plugged-in without any problems.
This project was initially planned as a proof-of-concept to evaluate whether
statistically relevant results can be generated for analyzes of highly complex
and noisy mass data. This has been fully achieved and has even exceeded
former expectations. The next two paragraphs describe necessary and optional
extensions to this successfull initial research to devise new ways of analyzing
mass spectrometry data and exploit their wealth of lurking information content.
2Group of Prof. Thiery, University Hospital Leipzig
3By Bruker Daltronics, worldmarket leader in MALDI-TOF mass spectrometry devices.
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